Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Péter Bacsúr"'
Autor:
Péter Bacsur, Tamás Resál, Patrícia Sarlós, Ákos Iliás, Liza Dalma Sümegi, Diána Kata, Anett Dávid, Bernadett Farkas, Emese Ivány, Anita Bálint, Zsófia Bősze, Anna Fábián, Renáta Bor, Zoltán Szepes, Waqqas Afif, Talat Bessissow, Klaudia Farkas, Péter L. Lakatos, Tamás Molnár
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 17 (2024)
Background: The usability of subcutaneous vedolizumab (s.c. VDZ) treatment in inflammatory bowel diseases (IBD; ulcerative colitis (UC), Crohn’s disease (CD)) has been proven via clinical trials while real-world data collection is ongoing. Objectiv
Externí odkaz:
https://doaj.org/article/c22a45855e894d3eb5843d9997f140aa
Autor:
Béla Vasas, Anna Fábián, Zsófia Bősze, Sándor Hamar, László Kaizer, Tibor Tóth, Péter Bacsur, Tamás Resál, Anita Bálint, Klaudia Farkas, Tamás Molnár, Zoltán Szepes, Renáta Bor
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 17 (2024)
Background: The standardized diagnostic categories defined by the World Health Organization (WHO) reporting system support the interdisciplinary interpretation of cytological findings in the management of pancreatic cancer. Objective: To compare this
Externí odkaz:
https://doaj.org/article/c0d6992cef124695995d445f8cdffa5d
Autor:
Péter Bacsur, Tamás Resál, Bernadett Farkas, Boldizsár Jójárt, Zoltán Gyuris, Gábor Jaksa, Lajos Pintér, Bertalan Takács, Sára Pál, Attila Gácser, Kata Judit Szántó, Mariann Rutka, Renáta Bor, Anna Fábián, Klaudia Farkas, József Maléth, Zoltán Szepes, Tamás Molnár, Anita Bálint
Publikováno v:
Biomedicines, Vol 12, Iss 9, p 2100 (2024)
Alterations to intestinal microbiota are assumed to occur in the pathogenesis of inflammatory bowel disease (IBD). This study aims to analyze the association of fecal microbiota composition, body composition, and lipid characteristics in patients wit
Externí odkaz:
https://doaj.org/article/fe40db87fa674bcc96e21d1bca3d7362
Autor:
Péter Bacsur, Panu Wetwittayakhlang, Tamás Resál, Emese Földi, Béla Vasas, Bernadett Farkas, Mariann Rutka, Talat Bessissow, Waqqas Afif, Anita Bálint, Anna Fábián, Renáta Bor, Zoltán Szepes, Klaudia Farkas, Peter L Lakatos, Tamás Molnár
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 17 (2024)
Background: Different endoscopic scoring systems for assessing ulcerative colitis (UC) severity are available. However, most of them are not correlated with disease extent. Objectives: Our study aimed to compare the predictive value of the PanMay sco
Externí odkaz:
https://doaj.org/article/3145a2041e99493e847d9a692c64d678
Autor:
Tamás Resál, Péter Bacsur, Miklós Horváth, Kata Szántó, Mariann Rutka, Anita Bálint, Anna Fábián, Renáta Bor, Zoltán Szepes, János Fekete, Klaudia Farkas, Pál Miheller, Tamás Molnár
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 16 (2023)
Background: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has complicated the management of inflammatory bowel diseases (IBD). Objectives: This study aimed to assess the efficacy of different anti-SARS-CoV-2 vaccines under
Externí odkaz:
https://doaj.org/article/b1f9e6a9761e44acac8f376eb272a6e8
Autor:
Péter Bacsur, Mariann Rutka, András Asbóth, Tamás Resál, Kata Szántó, Boldizsár Jójárt, Anita Bálint, Eszter Ari, Walliyulahi Ajibola, Bálint Kintses, Tamás Fehér, Daniella Pigniczki, Renáta Bor, Anna Fábián, József Maléth, Zoltán Szepes, Klaudia Farkas, Tamás Molnár
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 16 (2023)
Background: In patients with inflammatory bowel disease (IBD), Crohn’s disease (CD), and ulcerative colitis (UC), numerous cases of exacerbations could be observed after colonoscopy, raising the possible pathogenetic effect of colonic microbiota al
Externí odkaz:
https://doaj.org/article/c8c16ced6d8d4eaa9ed5da00b1476810
Autor:
Tamás Resál, Mária Matuz, Csilla Keresztes, Péter Bacsur, Kata Szántó, Anett Sánta, Mariann Rutka, Diána Kolarovszki-Erdei, Renata Bor, Anna Fábián, Zoltán Szepes, Pál Miheller, Patrícia Sarlós, Anita Zacháry, Klaudia Farkas, Tamás Molnár
Publikováno v:
Vaccine: X, Vol 13, Iss , Pp 100253- (2023)
Introduction: Inflammatory bowel disease potentially elevates the risk of infections, independently from age, while the disease activity and medical treatment(s) can also increase the risks. Nevertheless, it is necessary to clarify these preconceptio
Externí odkaz:
https://doaj.org/article/bef18fcb500f4bc6946cfb7636ac1936
Autor:
Péter Bacsur, Mária Matuz, Tamás Resál, Pál Miheller, Tamás Szamosi, Eszter Schäfer, Patrícia Sarlós, Ákos Iliás, Kata Szántó, Mariann Rutka, Anita Bálint, Ágnes Milassin, Anna Fábián, Renáta Bor, Zoltán Szepes, Tamás Molnár, Klaudia Farkas
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 15 (2022)
Background: Treatment with antitumor necrosis factor alpha (anti-TNF-α) is safe and effective as first-line therapy; however, its efficacy is limited due to primary nonresponse (PNR) and secondary loss of response (LOR), resulting in treatment disco
Externí odkaz:
https://doaj.org/article/edcf0fc449174682b11bc1c621e4b363
Autor:
Renáta Bor, Béla Vasas, Anna Fábián, Mónika Szűcs, Zsófia Bősze, Anita Bálint, Mariann Rutka, Klaudia Farkas, Tibor Tóth, Tamás Resál, Péter Bacsur, Tamás Molnár, Zoltán Szepes
Publikováno v:
Diagnostics, Vol 13, Iss 17, p 2841 (2023)
Background: The inconclusive cytological findings of endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) remain a major clinical challenge and often lead to treatment delays. Methods: Patients who had undergone EUS-FNA sampling for solid pa
Externí odkaz:
https://doaj.org/article/c208f518ec794315a2425b7aa5a461ea
Publikováno v:
Frontiers in Nutrition, Vol 9 (2022)
The leakage of the intestinal barrier and the disruption of the gut microbiome are increasingly recognized as key factors in different pathophysiological conditions, such as irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), chronic li
Externí odkaz:
https://doaj.org/article/f6dbfc612ebc49e28dc72def4d8c9993